04/26/2024
4:22 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:18 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:20 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:57 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
4:59 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:01 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:05 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/19/2024
5:06 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:18 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:14 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:16 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:54 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:31 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:34 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:37 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:39 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:44 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:46 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:48 PM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:50 PM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:23 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:27 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:29 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:14 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:16 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:18 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:21 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:47 AM | Deep Track Capital, LP (Filed by)
Immunovant (Subject)
| Form SC 13G/A | |
02/12/2024
6:02 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:05 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/09/2024
8:16 AM | Immunovant (Subject)
| Form SC 13G | |
01/19/2024
3:04 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:29 AM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/12/2024
3:34 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:18 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:20 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:08 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:37 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
3:25 PM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:28 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:30 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
How a $0.25 cent option contract makes my top traders feel (Ad) If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time!
While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about |
12/01/2023
3:19 PM | Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:19 PM | Fromkin Andrew J. (Reporting)
Immunovant (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:20 PM | Immunovant (Subject)
Pande Atul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023
6:43 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
1:55 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
1:45 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
1:47 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
1:51 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2023
1:41 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
7:49 AM | Immunovant (Filer)
| Form S-3ASR | |
11/09/2023
6:06 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:13 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023
3:06 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
3:11 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
4:10 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
4:15 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
4:15 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
4:19 PM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A | |
09/29/2023
3:48 PM | Immunovant (Filer)
| Form 424B5 | |
09/28/2023
4:23 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
5:09 AM | Immunovant (Subject)
| Form FWP | |
09/26/2023
7:00 PM | Immunovant (Subject)
| Form FWP | |
09/26/2023
4:28 PM | Immunovant (Filer)
| Form 424B5 | |
09/26/2023
6:45 AM | Immunovant (Filer)
Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/25/2023
4:00 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
4:03 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
4:05 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:57 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:48 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:11 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
6:19 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:10 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2023
3:35 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
3:37 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
4:10 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
4:11 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:35 AM | Immunovant (Filer)
| Form DEFA14A | |
06/26/2023
6:26 AM | Immunovant (Filer)
| Form DEF 14A | |
05/22/2023
6:03 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
6:10 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
